Skip to main content
Equibles

FIRST MANHATTAN CO. LLC.

Position in VRTX — Vertex Pharmaceuticals Inc / Ma

CIK 728083 NEW YORK, NY
Back to VRTX Full portfolio

Position in VRTX

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$774,898
+$78,296 QoQ
Shares Held
1,560
0.0% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 0% Shared 100% None 0%

Common Shares in VRTX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

FIRST MANHATTAN CO. LLC. holds $1,927,732 across 8 Biotechnology names. VRTX ranks #1 (40.2% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
This page 		1,560 $774,898
2 ROIV
Roivant Sciences Ltd.
 11,146 $394,456
3 TSHA
Taysha Gene Therapies, Inc.
 43,500 $296,235
4 IMRX
Immuneering Corp
 24,245 $120,982
5 IOVA
Iovance Biotherapeutics, Inc.
 27,998 $116,471
6 IBRX
ImmunityBio, Inc.
 10,000 $87,550
7 OVID
Ovid Therapeutics Inc.
 26,000 $69,940
8 ABUS
Arbutus Biopharma Corp
 14,000 $67,200

All Filings in VRTX

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $774,898 1,560
2026-03-31 $696,602 1,560
2025-12-31 $933,468 2,059
2025-09-30 $618,791 1,580
2025-06-30 $705,642 1,585
2025-03-31 $753,895 1,555
2024-12-31 $626,198 1,555
2024-09-30 $730,175 1,570
2024-06-30 $728,859 1,555
2024-03-31 $649,587 1,554
2023-12-31 $604,638 1,486
2023-09-30 $542,474 1,560
2023-06-30 $546,516 1,553
2023-03-31 $480,481 1,525
2022-12-31 $450,208 1,559
2022-09-30 $448,787 1,550
2022-06-30 $493,132 1,750
2022-03-31 $456,697 1,750
2021-12-31 $384,300 1,750
2021-09-30 $317,432 1,750
2021-06-30 $352,852 1,750
2021-03-31 $462,013 2,150
2020-12-31 $531,765 2,250
2020-09-30 $620,705 2,281
2020-06-30 $683,680 2,355
2020-03-31 $554,423 2,330